Nimesulide Dosage Recommendations
The recommended maximum daily dose of nimesulide for adults is 200-400 mg per day, administered as 100-200 mg twice daily, either orally or rectally. 1, 2
Standard Adult Dosing
- The typical therapeutic regimen is 100-200 mg twice daily (total daily dose: 200-400 mg), given orally or rectally 1, 2
- Doses up to 400 mg twice daily (800 mg total daily) have been studied but were associated with gastrointestinal adverse effects (abdominal pain and indigestion) in the majority of subjects 3
- Doses of 400-600 mg daily (200-300 mg twice daily) were well tolerated without clinically significant adverse effects 3
- The drug should be administered twice daily due to its elimination half-life of approximately 2-5 hours 4
Pharmacokinetic Considerations
- Nimesulide reaches peak plasma concentrations within 1-4 hours after oral administration 4
- Steady-state is achieved within 24-36 hours (2-3 doses) with twice-daily administration 4
- Only modest drug accumulation occurs with the standard 100 mg twice daily regimen 4
- Food does not significantly affect absorption, so the medication can be taken with or without meals 4
Special Population Adjustments
Elderly Patients (< 80 years)
- No dosage adjustment is necessary for elderly patients under 80 years of age when using the standard 100 mg twice daily regimen 1
- The pharmacokinetic profile remains unchanged in this population 1
Renal Impairment
- Patients with moderate renal insufficiency do not require dosage adjustment 1
- While the hydroxy metabolite shows slightly prolonged elimination and minimal accumulation, this is not considered clinically significant 1
- Nimesulide should be avoided entirely in patients with severe renal failure until the significance of metabolite accumulation is better characterized 1
Pediatric Patients
- For children aged 7-9 years, a 50 mg dose in granular formulation has been studied 1
- Children in this age range showed greater absorption and elimination compared to adults 1
- Further pharmacokinetic assessment is needed for children under 7 years before definitive dosing recommendations can be made 1
Key Contraindications and Precautions
- Avoid in patients with active peptic ulcer disease or gastrointestinal bleeding 2
- Avoid in patients with severe renal impairment 1
- Exercise caution with concurrent anticoagulant therapy due to NSAID-related bleeding risk 2
- Monitor for typical NSAID adverse effects including gastrointestinal, dermatological, and neurological symptoms 2
Clinical Efficacy Context
- Nimesulide has demonstrated efficacy comparable to or better than other NSAIDs for pain and inflammation 2
- It may have a reduced propensity for gastrointestinal adverse effects compared to traditional NSAIDs, though this has not been definitively proven in all comparative trials 2
- The drug has been well tolerated in most aspirin-intolerant and NSAID-intolerant patients 2